Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




AACC Meeting Highlights New Tests and Research to Better Detect Heart Attacks

By LabMedica International staff writers
Posted on 10 Aug 2015
AACC 2015 (July 26-30; Atlanta, GA, USA), leading global conference of lab medicine experts, highlights new clinical tests and real-time research to improve heart attack detection. More...
New handheld technologies for faster, simpler testing will also be on display.

The 2015 AACC Annual Meeting & Clinical Lab Expo (July 26–30, Atlanta, GA, USA), leading annual event for laboratory medicine, opened Sunday, July 26. This year’s meeting will host more than 400 educational sessions on topics ranging from personalized medicine and infectious diseases to point-of-care (POC) and laboratory-developed tests, and will feature more than 200 new cutting edge diagnostic products.

In addition to symposia, plenary sessions, courses, and poster sessions, AACC 2015 will showcase first-ever live research experiment to improve testing methods to identify heart attacks and risk of their future occurrence. AACC 2015 attendees will have the opportunity to donate blood samples onsite that will be studied in a groundbreaking scientific initiative to improve testing for heart attacks. The aim of this initiative is to establish a baseline for the protein troponin in healthy adults. This research will help accelerate the differentiation of heart attacks from other conditions with similar symptoms in the emergency room, and improve identification of patients at increased risk for cardiovascular events.

The latest tools from top medical diagnostics manufacturers. Exhibitors will show the latest in POC diagnostic tests, as well as tests that will be less invasive, faster, and cheaper. These include the Abbott Point of Care (Princeton, NJ, USA) i-STAT Total β-hCG, the first and only handheld blood test for pregnancy. Research has shown that 9 out of the 11 most popular hospital urine pregnancy tests are unreliable after the first few weeks of pregnancy. In emergency situations, this new blood test could play a crucial role in accurately determining a woman’s pregnancy status before she receives medical treatment that could harm her baby. The Siemens Healthcare Diagnostics’ (Tarrytown, NY, USA) Xprecia Stride Coagulation Analyzer, winner of the prestigious 2015 Red Dot Award for product design. This is the first handheld instrument that enables healthcare providers to determine—in the course of a regular doctor’s office visit—whether a patient who is on blood-thinning medication for the prevention of heart attack and stroke is at risk for uncontrollable bleeding.

AACC's annual meeting offers 5 days with opportunities to learn about exciting science. Plenary sessions feature expert presentations on using tumor DNA in the blood to diagnose and monitor cancer, reducing the risk of heart disease, transparency in healthcare delivery, the latest advances that could lead to a cure for HIV, and new tests and treatments for infection. At the AACC Clinical Lab Expo, over 700 exhibitors will fill the show floor of Atlanta’s convention center, Georgia World Congress Center, with displays of the latest diagnostic technology, including mobile health, molecular diagnostics, mass spectrometry, point-of-care, automation, and more.

Related Links:

American Association for Clinical Chemistry (AACC)
AACC 2015 Annual Meeting & Clinical Lab Expo



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Measuring six variants from one sample may improve research efficiency and support clinical trials of amyloid biology in Alzheimer’s disease and related conditions (Image Credit: Adobe Stock)

Plasma Assay Measures Six Amyloid Beta Peptides for Alzheimer’s Treatment Research

Alzheimer’s disease research and related neurological studies often require tools that can characterize brain amyloid pathology and amyloid beta biology. Blood-based biomarker assays may help researchers... Read more

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.